Innovating Works

INSTITUTE FOR MEDICAL RESEARCH AND OCCUP...

Desconocido
EvaMobs: Evolvable and rapidly adaptable monobodies: a broad-spectrum antiviral platform INSTITUT ZA MEDICINSKA ISTRAZIVANJA I MEDICINU RADA participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 With progress in globalization, expansion of human populations into natural habitats, and aggravation of climate change comes an increased r...
2023-11-23 - 2028-12-31 | Financiado
NABIHEAL: ANTIMICROBIAL NANOSTRUCTURED BIOMATERIALS FOR COMPLEX WOUND HEALING INSTITUT ZA MEDICINSKA ISTRAZIVANJA I MEDICINU RADA participó en un HORIZON EUROPE: HORIZON-CL4-2022-RESILIENCE-01 Complex wounds impact the quality of life of more than 2% of total population in developed countries being a global health problem with sign...
2022-11-29 - 2026-12-31 | Financiado
EDIAQI: EVIDENCE DRIVEN INDOOR AIR QUALITY IMPROVEMENT INSTITUT ZA MEDICINSKA ISTRAZIVANJA I MEDICINU RADA participó en un HORIZON EUROPE: HORIZON-HLTH-2021-ENVHLTH-02 Indoor air pollution, an emerging threat recognized by European society, is claiming millions of lives annually. In the heat of current COVI...
2022-11-22 - 2026-11-30 | Financiado
PIANOFORTE: Partnership for european research in radiation protection and detection of ionising radiation : towa... INSTITUT ZA MEDICINSKA ISTRAZIVANJA I MEDICINU RADA participó en un HORIZON EUROPE: HORIZON-EURATOM-2021-NRT-01 The ambition of the PIANOFORTE Partnership is to improve radiological protection of members of the public, patients, workers and environment...
2022-06-08 - 2027-05-31 | Financiado
PARC: Partnership for the Assessment of Risks from Chemicals INSTITUT ZA MEDICINSKA ISTRAZIVANJA I MEDICINU RADA participó en un HORIZON EUROPE: HORIZON-HLTH-2021-ENVHLTH-03 PARC is an EU-wide research and innovation partnership programme to support EU and national chemical risk assessment and risk management bod...
2022-05-24 - 2029-04-30 | Financiado
Phoenix: Pharmaceutical Open Innovation Test Bed for Enabling Nano pharmaceutical Innovative Products INSTITUT ZA MEDICINSKA ISTRAZIVANJA I MEDICINU RADA participó en un H2020: H2020-NMBP-TO-IND-2018-2020 Nano-pharmaceuticals have the potential to drive the scientific and technological uplift, offering great clinical and socio-economic benefit...
2020-12-16 - 2025-02-28 | Financiado
RiskGONE: Risk Governance of Nanotechnology INSTITUT ZA MEDICINSKA ISTRAZIVANJA I MEDICINU RADA participó en un H2020: H2020-NMBP-TO-IND-2018-2020 Engineered nanomaterials (ENMs) are covered by REACH/CLP regulations; the general opinion is that the risk assessment (RA) approach routinel...
2018-12-19 - 2023-08-31 | Financiado
HBM4EU: European Human Biomonitoring Initiative INSTITUT ZA MEDICINSKA ISTRAZIVANJA I MEDICINU RADA participó en un H2020: H2020-SC1-2016-2017 The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemi...
2016-12-09 - 2022-06-30 | Financiado
CONCERT: European Joint Programme for the Integration of Radiation Protection Research INSTITUT ZA MEDICINSKA ISTRAZIVANJA I MEDICINU RADA participó en un H2020: NFRP-2014-2015 The proposed European Concerted Programme on Radiation Protection Research (acronym: CONCERT) aims to contribute to the sustainable integrat...
2015-07-13 - 2020-05-31 | Financiado
CYTOTHREAT: Fate and effects of cytostatic pharmaceuticals in the environment and the identification of biomarke... INSTITUT ZA MEDICINSKA ISTRAZIVANJA I MEDICINU RADA participó en un FP7: CytoThreat addresses the need to assess the risks of pharmaceuticals released in the environment, focusing on cytostatic drugs because they...
Financiado
COPHES: European coordination action on human biomonitoring INSTITUT ZA MEDICINSKA ISTRAZIVANJA I MEDICINU RADA participó en un FP7: This proposal has been elaborated by a consortium of 35 partners coming from 27 European countries and including scientists, government inst...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.